Castle Biosciences Inc (CSTL)
23.88
-0.53
(-2.17%)
USD |
NASDAQ |
May 07, 11:29
Castle Biosciences Cash from Financing (TTM): 7.618M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 7.618M |
December 31, 2023 | -2.298M |
September 30, 2023 | 0.249M |
June 30, 2023 | 0.592M |
March 31, 2023 | 1.027M |
December 31, 2022 | 1.515M |
September 30, 2022 | 2.391M |
June 30, 2022 | 3.897M |
March 31, 2022 | 5.127M |
December 31, 2021 | 5.421M |
September 30, 2021 | 233.12M |
Date | Value |
---|---|
June 30, 2021 | 239.37M |
March 31, 2021 | 306.84M |
December 31, 2020 | 305.89M |
September 30, 2020 | 78.29M |
June 30, 2020 | 146.56M |
March 31, 2020 | 78.14M |
December 31, 2019 | 88.29M |
September 30, 2019 | 92.48M |
June 30, 2019 | 16.10M |
March 31, 2019 | 21.20M |
December 31, 2018 | 15.84M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-2.298M
Minimum
Dec 2023
306.84M
Maximum
Mar 2021
80.53M
Average
11.86M
Median
Cash from Financing (TTM) Benchmarks
Exact Sciences Corp | 159.77M |
Illumina Inc | -702.00M |
Mettler-Toledo International Inc | -859.58M |
Waters Corp | 754.95M |
Natera Inc | 254.46M |